JUN 30, 2015 12:48 PM PDT

Vanderbilt Chemists Organize a Microbial Fight Club

WRITTEN BY: Kerry Evans
Bacteria produce a medley of secondary metabolites in response to their environment. Often, these metabolites are used to fend off rival microorganisms, making them ideal antibacterial and anticancer drug candidates. However, many of these metabolites are not produced when bacteria are grown in monoculture. A group of Vanderbilt University chemists solved this problem by organizing a microbial fight club.

Brian Bachmann, Associate Professor of Chemistry, and John McLean, Stevenson Professor of Chemistry, describe their unique approach to drug discovery in the journal ACS Chemical Biology (ACS Chem Biol. 2015 Jun 17). The group co-cultured the soil-dwelling bacterium Nocardiopsis with Escherichia coli, Bacillus subtilis, Rhodococcus wratislaviensis, and Tsukamurella pulmonis.

Vanderbilt University chemists designed a bacterial fight club to discover new drugs.
They looked for secondary metabolites in the co-culture media using ion mobility-mass spectrometry, a technique that sorts molecules based on their size to weight ratio. This approach identified upwards of 2,500 unique molecules from each co-culture. In each case, more metabolites were found in the co-culture than in either individual culture combined, suggesting that unique metabolites were produced when different species interacted.

To identify metabolites that were similar in structure to known antibiotics and anticancer drugs, the researchers developed a "self-organizing metabolomics map". This approach identified a unique metabolite from the Nocardiopsis/Rhodococcus co-culture, a macrolactam type polyketide now named "ciromicin".

This isn't the Bachmann Lab's only creative approach to drug discovery. In collaboration with Hazel Barton, Professor of Microbiology and Geology at the University of Akron, Bachmann looked for novel antibiotics made by cave-dwelling bacteria. One sample from Lechuguilla Cave in New Mexico contained 38 antibiotic compounds, an impressive figure when you consider there are fewer than 100 known antibiotics.

Sources: ACS Chemical Biology, Science Daily, BBC
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
DEC 04, 2019
Clinical & Molecular DX
DEC 04, 2019
Genetic platform takes the guesswork out of catching infections
A physician is faced with 3 patients: an elderly person with a chronic cough, a child being wheeled out of surgery and a young mother with a high fever. Ho...
DEC 11, 2019
Microbiology
DEC 11, 2019
Ocean Microbes Demonstrate an Evolutionary Principle in Action
Our world is teeming with bacteria and viruses, and in the oceans, their coexistence has them locked in an evolutionary battle....
DEC 22, 2019
Microbiology
DEC 22, 2019
Viruses Can Escape the Effects of CRISPR by Shielding Their Genomes
Our world is filled with microbes, and in every kind of environment, they compete for supremacy, a competition that dates back to the origins of life....
JAN 15, 2020
Microbiology
JAN 15, 2020
Scientists Engineer a New Kind of Life Form
Usig cells harvested from frogs, researchers created tiny robots....
FEB 12, 2020
Microbiology
FEB 12, 2020
Using Genomics to Learn More About a Mumps Outbreak
Though vaccination rates are high, small mumps outbreaks sometimes still occur....
FEB 14, 2020
Microbiology
FEB 14, 2020
CDC Director Expects Coronavirus to Find a "Foothold"
The novel coronavirus that emerged in Wuhan, Hubei Province, China has now infected over 64,000 people....
Loading Comments...